You just read:

CIMTEC announces spin-off company Focal Healthcare, Inc. to develop the new "gold standard" of targeted prostate biopsy and therapy devices for the management of prostate cancer

News provided by

Centre for Imaging Technology Commercialization (CIMTEC)

Jul 09, 2014, 09:00 ET